Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
St Luke's Clinic - Idaho Cardiology Associates
mi
from
Boise, ID
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Chicago Medical Research, LLC
mi
from
Hazel Crest, IL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
York Clinical Research, LLC
mi
from
Norfolk, VA
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
UNC Rex Healthcare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
East Coast Institute for Research LLC
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Cozy Research LLC
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Med Research One
mi
from
Florissant, MO
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
The DOCS
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Heart Research Foundation
mi
from
Mineola, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of America LA, LLC
mi
from
West Monroe, LA
Click here to add this to my saved trials
Focal Segmental Glomerulosclerosis (FSGS) Clinical Trial
Trial To Evaluate PF-06730512 In Adults With Primary Focal Segmental Glomerulosclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Presbyterian-Queens Hospital
mi
from
Flushing, NY
Click here to add this to my saved trials
Chronic Cough Clinical Trial
Phase 3 Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Solutions of Arizona
mi
from
Litchfield Park, AZ
Click here to add this to my saved trials
Chronic Cough Clinical Trial
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Lung Research Center
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Chronic Cough Clinical Trial
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlantic Research Center, LLC
mi
from
Ocean City, NJ
Click here to add this to my saved trials
PAH Clinical Trial
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
Status: Enrolling, Phase II
Updated: 12/31/1969
Abbott Northwestern Hospital, Allina Health System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Brighan and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Cancer Institute at Baptist Health, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Easing Psychosocial Burden for Informal Caregivers
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Westchester (Consent only)
mi
from
Harrison, NY
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange
mi
from
Orange, CA
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Urology Institute
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Chesapeake Urology
mi
from
Hanover, MD
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Collection of Sputum and Labeling for Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Radiology Associates of Albuquerque
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Collection of Sputum and Labeling for Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Atlantic Respiratory Institute
mi
from
Summit, NJ
Click here to add this to my saved trials
Reproductive Clinical Trial
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
Status: Enrolling, Phase
Updated: 3/2/2018
Nickalus Children's Hospital f/k/a Miami Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Urinary Bladder Neoplasms Clinical Trial
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Urinary Bladder Neoplasms Clinical Trial
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
Urinary Bladder Neoplasms Clinical Trial
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Psychiatry / Psychology, Reproductive Clinical Trial
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
Status: Enrolling, Phase II
Updated: 12/31/1969
Marinus Research Site
mi
from
Irving, TX
Click here to add this to my saved trials
Psychiatry / Psychology, Reproductive Clinical Trial
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
Status: Enrolling, Phase II
Updated: 12/31/1969
Marinus Research Site
mi
from
Media, PA
Click here to add this to my saved trials
Psychiatry / Psychology, Reproductive Clinical Trial
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
Status: Enrolling, Phase II
Updated: 12/31/1969
Marinus Research Site
mi
from
Orem, UT
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
NEXT Oncology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Thyroid Eye Disease Clinical Trial
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study
Status: Enrolling, Phase III
Updated: 12/31/1969
The Lennar Foundation Medical
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Thyroid Eye Disease Clinical Trial
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospital Essen, Department of Ophthalmology
mi
from
Essen,
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Hatton Institute for Research & Education, Trihealth, Inc. - cardiology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Sima Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Digestive Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Fargo Gastroenterology Clinic, PC
mi
from
Fargo, ND
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Hazard
mi
from
Hazard, KY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Duluth Clinic Ashland
mi
from
Ashland, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Bloomfield
mi
from
Bloomfield, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Good Samaritan Medical Center
mi
from
Lafayette, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Virginia Clinic
mi
from
Virginia, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Farmington Health Center
mi
from
Farmington, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC-Coraopolis/Heritage Valley Radiation Oncology
mi
from
Moon, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
South Jordan Health Center
mi
from
South Jordan, UT
Click here to add this to my saved trials
Ischemia-Reperfusion Injury Clinical Trial
Remote Ischemic Conditioning Using the autoRIC
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Traumatic Brain Injury Clinical Trial
Brain Injury Rehabilitation Improving the Transition Experience
Status: Enrolling
Updated: 12/31/1969
Moss Rehab Hospital
mi
from
Elkins Park, PA
Click here to add this to my saved trials
Primary Focal Segmental Glomerulosclerosis Clinical Trial
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
Status: Enrolling, Phase II
Updated: 12/31/1969
Albert Einstein College of Medicine, Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Non-Cystic Fibrosis Bronchiectasis Clinical Trial
Assessment of INS1007 in Subjects With Non-Cystic Fibrosis Bronchiectasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Hillman Cancer Center at Washington
mi
from
Washington, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Depressive Disorder, Treatment-Resistant Clinical Trial
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
Muscular Injury Clinical Trial
Pea Protein Supplementation and Muscle Damage
Status: Enrolling
Updated: 12/31/1969
Appalachian State University Human Performance Lab, North Carolina Research Campus
mi
from
Kannapolis, NC
Click here to add this to my saved trials
Fatty Liver Clinical Trial
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Lenus Research & Medical Group
mi
from
Sweetwater, FL
Click here to add this to my saved trials
GSD1 Clinical Trial
Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UT Health - McGovern Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Gynecologic Surgery Clinical Trial
Pilot Trial of the Robotic Uterine Manipulator
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Rockville (Consent only)
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
HIV Clinical Trial
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
Status: Enrolling, Phase III
Updated: 12/31/1969
One Community Health
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endometrial Neoplasms Clinical Trial
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwestern Regional Medical Center
mi
from
Zion, IL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Flint, MI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Effect of Efpeglenatide on Cardiovascular Outcomes
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Alzheimer Disease (AD) Clinical Trial
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Julie B. Schwartzbard, MD, PA
mi
from
Aventura, FL
Click here to add this to my saved trials